Development of Novel Fluticasone/Salmeterol/Tiotropium-Loaded Dry Powder Inhaler and Bioequivalence Assessment to Commercial Products in Rats
<b>Background</b>/<b>Objectives</b>: Inhaler devices have been developed for the effective delivery of inhaled medications used in the treatment of pulmonary diseases. However, differing operating procedures across the devices can lead to user errors and reduce treatment effi...
Saved in:
Main Authors: | Hyukjun Cho, Hyunji Lee, Duhyeong Hwang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-01-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/17/1/103 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Association of Corticosteroid Inhaler Type with Saliva Microbiome in Moderate-to-Severe Pediatric Asthma
by: Amir Hossein Alizadeh Bahmani, et al.
Published: (2025-01-01) -
Optimization of Carrier-Based Dry Powder Inhaler Performance: A Review
by: Tanu Mehta, et al.
Published: (2025-01-01) -
Evaluation of Inhaler Technique in Patients with Asthma and Chronic Obstructive Pulmonary Disease in Andaman and Nicobar Islands – An Observational Study
by: M. Natraj, et al.
Published: (2025-01-01) -
Numerical analysis of collision mechanism that causes particle tribocharging in dry powder inhaler
by: Ryosuke Mitani, et al.
Published: (2025-01-01) -
Validated HPLC method for simultaneous determination of azelastine hydrochloride fluticasone propionate and oxymetazoline in nasal mucosa and nasopharyngeal swabs from real human samples
by: Neven N. Mikawy, et al.
Published: (2025-02-01)